| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/22/2007 | US20070065442 Compositions and methods for treating hyperimmune response in the eye |
| 03/22/2007 | US20070065441 Human PF4A receptors, nucleic acid encoding and antibodies binding thereto |
| 03/22/2007 | US20070065440 Antibody compositions and methods |
| 03/22/2007 | US20070065439 Antibodies against interleukin-1 beta |
| 03/22/2007 | US20070065438 Methods of inducing and maintaining immune tolerance |
| 03/22/2007 | US20070065437 Anti-CD3 antibody formulations |
| 03/22/2007 | US20070065436 Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies |
| 03/22/2007 | US20070065435 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065434 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065433 Methods and compositions for the treatment of meconium aspiration syndrome |
| 03/22/2007 | US20070065432 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 03/22/2007 | US20070065431 A polynucleotide encoding a monomeric non-antibody ligand having a loop partly modified or replaced by or amino acid(s); improved solubility; medical diagnosis; targets of drugs, steroids, pesticides, antigens, growth factors, tumour markers, cell surface proteins or viral coat proteins |
| 03/22/2007 | US20070065430 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 03/22/2007 | US20070065429 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques |
| 03/22/2007 | US20070065428 Early B-cell detection for selecting vaccines |
| 03/22/2007 | US20070065427 Agents that modulate immune cell activation and methods of use thereof |
| 03/22/2007 | US20070065426 Tumor necrosis factor binding ligands |
| 03/22/2007 | US20070065425 Anti-idiotypic antibody neutralizing the inhibitor activity of a factor viii inhibitor antibody |
| 03/22/2007 | US20070065411 Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
| 03/22/2007 | US20070065406 Homogeneous preparations of IL-28 and IL-29 |
| 03/22/2007 | US20070065368 Compositions and Methods for Suppressing Fibrocytes and for Detecting Fibrocyte Differentiation |
| 03/22/2007 | US20070065351 Transfer apparatus and system, and uses thereof |
| 03/22/2007 | CA2820201A1 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | CA2663633A1 Synthetic polyvalent carbohydrates as components of microbicides |
| 03/22/2007 | CA2625815A1 Anti-cd3 antibody formulations |
| 03/22/2007 | CA2622827A1 Pharmaceutical compound capable of inducing immune protective response against dengue virus having the capsid protein of the dengue virus |
| 03/22/2007 | CA2622610A1 Fish vaccine |
| 03/22/2007 | CA2622603A1 Method for preparing immunoglobulin libraries |
| 03/22/2007 | CA2622587A1 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 03/22/2007 | CA2622575A1 Prok2 antagonists and methods of use |
| 03/22/2007 | CA2621939A1 Therapeutic use of outer shigella protein f (os pf) |
| 03/22/2007 | CA2621373A1 Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| 03/22/2007 | CA2621363A1 Methods and compositions for modulating tumor cell activity |
| 03/22/2007 | CA2621248A1 Anti-human sr-b1 antibody reducing inflammation and treating auto-immunedisease |
| 03/22/2007 | CA2619298A1 Modified antigen binding molecules with altered cell signaling activity |
| 03/22/2007 | CA2618429A1 A hepatitis c virus non-structural ns3/4a fusion gene |
| 03/21/2007 | EP1764371A1 Agonist antibodies that bind to the LT-beta receptor, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1764113A1 Antibodies against lung cancer, antigens and methods of use thereof for treating lung cancer |
| 03/21/2007 | EP1764109A1 Agonist antibodies that bind to the TWEAK receptor Fn14, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1764108A1 Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides |
| 03/21/2007 | EP1764107A1 Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides |
| 03/21/2007 | EP1763539A1 Treatment of bacterial infections |
| 03/21/2007 | EP1763367A2 Improved adjuvant therapy of g250-expressing tumors |
| 03/21/2007 | EP1763366A1 Treatment of cancer |
| 03/21/2007 | EP1763365A2 Antibodies for selective apoptosis of cells |
| 03/21/2007 | EP1763364A2 Methods and compositions comprising supramolecular constructs |
| 03/21/2007 | EP1763361A2 Steroid sparing agents and their use |
| 03/21/2007 | EP1648504B1 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 03/21/2007 | EP1517703B1 Placental growth factor as a target for the treatment of osteoporosis |
| 03/21/2007 | EP1479396B1 Agent for controlling circadian rhythm disorder |
| 03/21/2007 | EP1467711B1 Dna dosage forms |
| 03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
| 03/21/2007 | EP1409014B1 Immunogenic compositions comprising an antigen and a purified m protein from respiratory syncytial virus |
| 03/21/2007 | EP1383534B1 Chalamydia vaccine based on blebs |
| 03/21/2007 | EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 03/21/2007 | EP1313771B1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 03/21/2007 | EP1296663B1 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/21/2007 | EP1292327B1 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
| 03/21/2007 | EP1126876B1 Adjuvant systems and vaccines |
| 03/21/2007 | EP1115425B1 Autoantibody inhibitors |
| 03/21/2007 | EP1105496B1 Modified hcv peptide vaccines |
| 03/21/2007 | EP1102600B1 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 03/21/2007 | EP1049717B1 Antibodies against human il-12 |
| 03/21/2007 | EP1019494B1 Stimulation of hematopoietic cells in vitro |
| 03/21/2007 | EP1007088B1 Recombinant porcine adenovirus vector |
| 03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
| 03/21/2007 | EP0574461B9 High affinity humanized monoclonal antibodies |
| 03/21/2007 | CN1934448A Method for the prevention of malaria |
| 03/21/2007 | CN1934266A Anti-myostatin antibodies |
| 03/21/2007 | CN1934255A Combination therapy for the treatment of ocular neovascular disorders |
| 03/21/2007 | CN1934248A HBV variants detection and application |
| 03/21/2007 | CN1934247A Cancerous disease modifying antibodies |
| 03/21/2007 | CN1934246A Cancerous disease modifying antibodies |
| 03/21/2007 | CN1934243A Immortalized avian cell lines for virus production |
| 03/21/2007 | CN1934240A Attenuated gram negative bacteria |
| 03/21/2007 | CN1934134A Methods for inducing autolysis in infectious bacteria |
| 03/21/2007 | CN1934127A A beta immunogenic peptide carrier conjugates and methods of producing same |
| 03/21/2007 | CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 03/21/2007 | CN1933853A Drug conjugates |
| 03/21/2007 | CN1933852A Improved inactivated FCV vaccines |
| 03/21/2007 | CN1933851A Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 03/21/2007 | CN1933849A Methods for treating pain and for treating a medication overuse disorder |
| 03/21/2007 | CN1931878A Platelet aggregation resistant chimeric monoclonal antibody and/or its fragment |
| 03/21/2007 | CN1931877A Prepn and use of CD20 antagonizing Chimeric antibody |
| 03/21/2007 | CN1931365A Hcv e1e2 vaccine compositions |
| 03/21/2007 | CN1931364A Prepn process of oral vaccine for antagonizing bacterial diseases of aquatic animal |
| 03/21/2007 | CN1931363A Toxoplasma metabolic secretion antigen vaccine and its prepn process |
| 03/21/2007 | CN1306272C In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 03/21/2007 | CN1306033C Production of vaccines |
| 03/21/2007 | CN1305906C Use of antibodies against specific MHC-Peptide complexes |
| 03/21/2007 | CN1305905C Humanized antibody and process for preparing same |
| 03/21/2007 | CN1305904C Human anti-tetanotoxin monoclonal antibody, method for preparation and application |
| 03/21/2007 | CN1305899C Therapeutic peptides |
| 03/21/2007 | CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 03/21/2007 | CN1305528C Immunoadjuvant |
| 03/21/2007 | CN1305527C Vaccine for treating hepatitis B, and its preparation. method |
| 03/21/2007 | CN1305526C Split encephalitis B virus vaccine and method for preparing the same |
| 03/21/2007 | CN1305525C 0157 bacterium gene engineering multivalence subunit vaccine of human and sensitive animals and its preparing method |
| 03/21/2007 | CN1305524C Mycoplasma hyopneumoniae bacterin vaccine |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |